Paul Little
Overview
Paul Little received $2M in total compensation, including $323K in salary, at Tokai Pharmaceuticals in 2021. Paul Little also received an average of $1M at Sientra from 2018 to 2020.
Source: SEC filings on April 28, 2022, April 28, 2021, April 22, 2020, and April 30, 2019.
Related executives
We found 21 more executives who work or worked at Tokai Pharmaceuticals and Sientra.
Ronald Menezes
Sientra
Chief Executive Officer
Andrew Schmidt
Sientra
Chief Financial Officer
Oliver Bennet
Sientra
Chief Legal, Compliance and Corporate Development Officer
Bryan Smith
Tokai Pharmaceuticals
General Counsel
David-Alexandre Gros
Tokai Pharmaceuticals
Chief Executive Officer
Caroline Van Hove
Sientra
Executive Chair of the Board
Jeffrey Nugent
Sientra
Chief Executive Officer
Charles Huiner
Sientra